Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings

Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin DalteparinAn Assessment of Safety and Pharmacodynamics: The DIRECT Study

(2008) James Douketis   ARCHIVES OF INTERNAL MEDICINE

Antithrombotic Therapy for Venous Thromboembolic Disease

(2008) Clive Kearon et al.   CHEST

Incidence of deep vein thrombosis in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass

(2008) Tomas Escalante-Tattersfield et al.   Surgery for Obesity and Related Diseases

Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity

(2008) Marilyn J. Borkgren-Okonek et al.   Surgery for Obesity and Related Diseases

Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery

(2008) Erin P. Simone et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

(2007) Elliott M. Antman et al.   CIRCULATION

Safety and efficacy of intravascular ultrasound-guided inferior vena cava filter in super obese bariatric patients

(2007) Clark M. Kardys et al.   Surgery for Obesity and Related Diseases